The Life Improvement Trial
The Life Improvement Trial (LIFT) Study AIM The Life Improvement Trial (LIFT) aims to investigate two drugs, separately and in combination, Pyridostigmine (commonly known as Mestinon) and Low-Dose Naltrexone (LDN), for efficacy and to research the difference between responders and non-responders. LEAD INVESTIGATORS David Systrom, MD Jonas Bergquist, MD/PhD Donna Felsenstein, MD Wenzhong Xiao, PhD […]